Gabapentin Use in Postoperative and Neuropathic Pain in Children

Marcia L. Buck, PharmD, FCCP, FPPAG


Pediatr Pharm. 2016;22(2) 

In This Article


Gabapentin has become a useful component of multimodal analgesic regimens for many patients. Although initially approved by the Food and Drug Administration in 1993 for the management of partial onset seizures, it is now considered a first-line treatment for the management of neuropathic pain.[1] Gabapentin is also increasingly being used in the postoperative setting to provide analgesia and reduce emergence reactions following anesthesia.[2,3] While not approved as an analgesic in children, a growing body of literature suggests that it may be a useful adjunct in the pediatric population.